SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoins pullback below the $80,000 level and reports of leveraged long liquidations are driving attention, with traders watching nearby support and debating whether the drop signals a deeper correction or a bear trap. Some are buying the dip, while others expect further losses; no single cause for the selloff is established in the discussion.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

TRUMP is drawing attention as holders debate its steep decline and allegations that the Trump family and insiders profited while retail buyers absorbed losses. Bears call it a cash grab and expect further selling, while some bulls speculate about a rebound or squeeze, including around a cited token unlock.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a broad crypto selloff, with traders pointing to Bitcoin weakness and leveraged-long liquidations as pressure on ETH. Bearish calls for further downside and broken support levels are competing with dip-buyers arguing the decline is a shakeout and a bottom may be forming.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins volatile moves around key support levels and reports of leveraged-position liquidations dominate discussion. Traders are split between warnings of further downside and dip-buying optimism, with ETF flows and U.S. crypto-policy developments also cited as potential support.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons proposed $1 billion zero-coupon convertible-note offering sparked dilution concerns and added to pressure on shares already weighed down by valuation and margin worries. Traders are debating whether the sharp decline has created a buying opportunity ahead of expected earnings, with some anticipating a rebound and others remaining cautious.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSkys expanded seven-figure Gen-3 Assured contract with an international defense partner is drawing attention alongside an after-hours move. Traders are reacting with optimism about growing customer demand, while others remain cautious about the stocks volatility and upcoming earnings.

WorldFinancial

Discussion centers on criticism that the Trump family profited from its crypto ventures while WLFI has remained weak, with some traders worried about selling pressure. Bulls counter that a potential bank charter and USD1-related utility could support the token, though those catalysts remain a source of speculation.

Dow, Inc. is a holding company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes, and construction of chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers, and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Dow Inc

Dow Inc. is trending as investors react to the company's latest earnings report, which featured a narrower-than-expected loss and ongoing cost-cutting initiatives. The community is actively debating the stock's long-term turnaround potential and its role as a high-dividend yield play despite persistent headwinds in the broader chemical manufacturing sector.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

A steep selloff in obesity-drug biotech shares has put GPCRs valuation and oral GLP-1 pipeline under scrutiny, with traders debating whether the decline reflects broader sector pressure or concerns about alenigliprons efficacy, tolerability and timeline to Phase 3 results. Some holders view the cash and pipeline as undervalued, while others remain cautious; buyout talk is speculation.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keetas Keeta Personal rollout and planned ACH, Visa Direct, and Bivo Cash payment integrations are driving discussion, with bulls viewing them as a step toward real-world fiat and payment use. Skeptics counter that delays, limited on-chain activity, and weak price action have yet to show meaningful adoption.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense Breast Cancer Cryoablation at Two U.S. Sites

IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense Breast Cancer Cryoablation at Two U.S. Sites IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense Breast Cancer Cryoablation at Two U.S. SitesPR NewswireCAESAREA, Israel, Oct. 20, 2026 CAESAREA, Israel, Oct. 20...

IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense Breast Cancer Cryoablation at EUSOBI 2026

IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense Breast Cancer Cryoablation at EUSOBI 2026 IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense Breast Cancer Cryoablation at EUSOBI 2026PR NewswireCAESAREA, Israel, October 13, 2026Scientific...

IceCure Expands ProSense ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site

IceCure Expands ProSense ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site IceCure Expands ProSense ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical SitePR NewswireCAESAREA, Israel, Oct. 6, 2026CAESAREA...

IceCure Secures China NMPA Approval for ProSense Cryoablation System

ICCM's NMPA approval for ProSense opens China to commercialization, expanding its global regulatory footprint and long-term revenue opportunity.

IceCure Medical Receives Regulatory Approval to Market ProSense in China

IceCure Medical Receives Regulatory Approval to Market ProSense in China IceCure Medical Receives Regulatory Approval to Market ProSense in China PR Newswire CAESAREA, Israel, Sept. 10, 2026 CAESAREA, Israel, Sept. 10, 2026 /PRNewswire/ --IceCure Medical Ltd.(NASDAQ: ICCM) ("IceCure," "IceCure...

IceCure Signs Exclusive Distribution Agreement for ProSense Cryoablation Systems in the Netherlands

IceCure Signs Exclusive Distribution Agreement for ProSense Cryoablation Systems in the Netherlands IceCure Signs Exclusive Distribution Agreement for ProSense Cryoablation Systems in the Netherlands PR Newswire CAESAREA, Israel, Aug. 24, 2026 Agreement expands ProSense commercialization in the...

West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation

West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation PR Newswire CAESAREA, Israel, Aug. 20, 2026 Patients are expected to enroll in the...

IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation PR Newswire CAESAREA, Israel, Aug. 13, 2026 New review by...

IceCure Medical Ltd Q2 2026 Earnings Call Summary

IceCure Medical Ltd Q2 2026 Earnings Call Summary...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Icecure Medical Ltd

ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>ProSense was granted FDA marketing authorization in October 2025.</li><li>The CEO hinted that the firm sees further commercial opportunities for the system.&nbsp;</li><li>According to data from Koyfin, all three analysts covering ICCM rate it ‘Buy’ or higher.</li></ul>Shares of IceCure Medical Ltd. (ICCM) exploded over 200% on Wednesday, fueled by positive news of accelerating adoption of the company’s ProSense system in the U.S.IceCure reported a 70% increase in its active U.S. commercial install base of ProSense systems used for breast cancer treatment since the FDA granted marketing authorization in October 2025.The stock is now on track for its best day since August 2021, if gains hold.<h2 class="st-heading-2">ICCM Execs Weigh In</h2>IceCure said it continues to add new ProSense systems at clinics and hospitals across the country. The systems are already being used for procedures in major cities, including Los Angeles, New York, Atlanta, Dallas, Detroit, Philadelphia, Phoenix, Memphis and many other communities.“With growing physician interest, expanding clinical acceptance, and increased patient awareness, we believe we remain in the early stages of a significant commercial opportunity for breast cancer cryoablation in the U.S. We are focused on continuing to expand our installed base, supporting physicians with training and education and increasing access to ProSense for eligible patients,” IceCure CEO Eyal Shamir said.<h2 class="st-heading-2">What Is ProSense?</h2>ProSense is a minimally invasive system that destroys tumors by freezing them with liquid nitrogen. It offers an alternative to traditional surgery for removing tumors, often with faster recovery, less pain, and fewer complications. Procedures can typically be done in an office setting.IceCure’s ProSense system is currently the first and only medical device specifically authorized by the FDA for the local treatment of low-risk breast cancer in women aged 70 and older, combined with standard hormone therapy, including patients who may not be suitable for surgery.<h2 class="st-heading-2">How Did ICCM Retail Traders React?</h2>On Stocktwits, retail sentiment toward ICCM stock surged from ‘bearish’ to ‘extremely bullish’ over the past 24 hours, while message volume climbed from ‘normal’ to ‘extremely high.’A Stocktwits user said that they see way more upside for the stock.<stembedurl>https://www.stocktwits.com/VlaDracula/message/6567163374</stembedurl>Another termed the stock an incredible investment opportunity.<stembedurl>https://www.stocktwits.com/Veghead12/message/656716302</stembedurl>According to data from Koyfin, all three analysts covering ICCM rate it ‘Buy’ or higher. The stock has an average price target of $44.50, representing a potential upside of nearly 2000% from the stock's last closing price.<a href="https://stocktwits.com/symbol/ICCM">ICCM stock</a> has lost about 67% this year after reporting persistent first-quarter losses.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/arqq-stock-on-track-for-a-four-month-high-what-s-driving-the-rally-june-17-2026/cZKKRz7R7IC">ARQQ Stock On Track For A Four-Month High – What’s Driving The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

IceCure reported a 70% increase in its active U.S. commercial install base of ProSense systems. 

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.01
Prev Close	$1.00
Open	$1.02
Dividend Yield	0.00%
50-Day Moving Average	$1.83
Beta	0.76
Avg. Volume	114,157.48
PE Ratio	-0.15

52-Week High	$24.36
52-Week Low	$0.9601
Market Capitalization	$3.46M
EPS (Annual)	-$7.10
Price to Book	0.29
Revenue Per Employee	$48,971.01

Feed

News

Sentiment

Earnings

Fundamentals

Info

ICCM Fundamentals